Agenus (AGEN) Interest & Investment Income (2010 - 2016)

Agenus (AGEN) posted quarterly Interest & Investment Income of -$765.0 for Q1 2016, up 95.01% quarter-over-quarter from -$15340.0 in Q4 2015.

Agenus (AGEN) Interest & Investment Income (2010 - 2016) Analysis & Trends

Agenus' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$765.0 for Q1 2016.

In Q1 2016, Interest & Investment Income changed N/A year-over-year to -$765.0; the TTM figure through Mar 2016 stood at -$2365.0 (changed N/A YoY), while the FY2025 annual figure was $345000.0, down 87.66% from the prior year.
Interest & Investment Income for Q1 2016 stood at -$765.0, up from -$15340.0 in the prior quarter.
The five-year high for Interest & Investment Income was $7760.0 in Q3 2015, with the low at -$15340.0 in Q4 2015.
The 3-year median for Interest & Investment Income is $1863.0 (2014), against an average of -$85.86.
Peak annual rise in Interest & Investment Income reached 316.53% in 2015, while the deepest fall reached 647.56% in 2015.
Agenus' Interest & Investment Income stood at -$2052.0 in 2014, then tumbled by 647.56% to -$15340.0 in 2015, then soared by 95.01% to -$765.0 in 2016.
Business Quant data shows AGEN's Interest & Investment Income at -$765.0 in Q1 2016, -$15340.0 in Q4 2015, and $7760.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	48.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	35.58 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	27.90 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	5.13 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	28.14 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	10.98 Mn
10	Agenus	311.95 Mn	286.43 Mn	34.52 Mn	-

Download Data